Suchergebnisse - "Yang, Wei"

PubPharm (111)

1

Real-world efficacy and safety of TACE plus camrelizumab and apatinib in patients with HCC (CHANCE2211) : a propensity score matching study

enthalten in: European radiology | 2023

von Jin, Z. | Zhong, B. | Chen, J. | +14

2

Proteomics, Transcriptomics, and Phosphoproteomics Reveal the Mechanism of Talaroconvolutin-A Suppressing Bladder Cancer via Blocking Cell Cycle and Triggering Ferroptosis

enthalten in: Molecular & cellular proteomics : MCP | 2023

von Xia, Y. | Xiang, L. | Yao, M. | +6

3

Near-Infrared Photothermal Manipulates Cellular Excitability and Animal Behavior in Caenorhabditis elegans

enthalten in: Small methods | 2023

von Zhuang, S. | He, M. | Feng, J. | +12

4

Mechanistic Insights into Harmine-Mediated Inhibition of Human DNA Methyltransferases and Prostate Cancer Cell Growth

enthalten in: ACS chemical biology | 2023

von Cho, C. | Lin, C. | Huang, H. | +5

5

Validation of the imatinib-therapy failure model

enthalten in: Leukemia | 2023

von Zhang, X. | Gale, R. | Liu, B. | +36

6

Hispolon Methyl Ether, a Hispolon Analog, Suppresses the SRC/STAT3/Survivin Signaling Axis to Induce Cytotoxicity in Human Urinary Bladder Transitional Carcinoma Cell Lines

enthalten in: International journal of molecular sciences | 2022

von Kuo, M. | Yang, W. | Ho, Y. | +5

7

Recent advances in the synthetic thymidine phosphorylase inhibitors for cancer therapy

enthalten in: European journal of pharmacology | 2022

von Feng, Q. | Yang, W. | Peng, Z. | +1

8

Neoadjuvant ceritinib treatment in ALK-rearranged locally advanced adenosquamous carcinoma : A case report

enthalten in: Thoracic cancer | 2022

von Mai, S. | Wang, Y. | Wang, X. | +8

ErratumIn: Thorac Cancer. 2023 Sep;14(25):2632. - PMID 37518989

9

Discovery of 3,4-Dihydrobenzo[f][1,4]oxazepin-5(2H)-one Derivatives as a New Class of Selective TNIK Inhibitors and Evaluation of Their Anti-Colorectal Cancer Effects

enthalten in: Journal of medicinal chemistry | 2022

von Li, Y. | Zhang, L. | Yang, R. | +9

10

Structural Optimization and Structure-Activity Relationship Studies of 6,6-Dimethyl-4-(phenylamino)-6H-pyrimido[5,4-b][1,4]oxazin-7(8H)-one Derivatives as A New Class of Potent Inhibitors of Pan-Trk and Their Drug-Resistant Mutants

enthalten in: Journal of medicinal chemistry | 2022

von Pan, S. | Zhang, L. | Luo, X. | +13

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[12]